Efficacy and immune correlates of the SRA737 plus LDG regimen in combination with anti-PD-L1 in an SCLC model

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

MYSTIC: Developing biomarkers for metastatic NSCLC

TATTON: Updated results for patients with EGFR-mutant NSCLC

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Perception of tobacco use in young adults of urban India

Nivolumab in combination with CIMAvax-EGF for lung cancer

Alcohol consumption and cognitive dissonance in the west

Large food and alcohol companies are undermining public health

Using genetics to close the knowledge gap on cancer causation